Judith C. Kando, PharmD, BCPP

  • 2Articles
  • 19.9KReads
  • 2017–2022Active
  • 13Collaborators
  • 32Citations

About

Judith C. Kando, PharmD, BCPP, is affiliated with Tris Pharma, Inc., Monmouth Junction, New Jersey. Her publications focus on clinical research related to Attention-Deficit/Hyperactivity Disorder and Eating Disorders, including studies on amphetamine extended-release formulations and screening tools for binge eating disorder. She has contributed to peer-reviewed articles published between 2017 and 2022 in Psychiatrist.com journals.

Publications

JCP
Amphetamine Extended-Release Tablets for Adult ADHD
Original Research

Amphetamine Extended-Release Tablets for Adult ADHD

July 20, 2022

Treating attention-deficit/hyperactivity disorder (ADHD) in adults can improve long-term outcomes, such as reducing suicidal behavior and mortality. This study evaluated the efficacy and safety of amphetamine extended-release tablets in...
, , , et al
PCC
Article

Use and Value of the BEDS-7

June 29, 2017

Binge-eating disorder may be underdiagnosed due to a lack of awareness and inadequate physician-patient communication. This report describes physician knowledge of and attitudes about binge-eating disorder and the value...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe